World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
40374
World Ranking
16887
National Ranking
1535

Overview

Philip N. Newsome is affiliated with the University of Birmingham in the United Kingdom. Their research primarily focuses on medicine, with a specialization in epidemiology, hepatology, endocrinology, diabetes and metabolism, surgery, and molecular biology.

The scientist has contributed extensively to the study of liver diseases and related metabolic conditions. Key topics in their work include:

  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Diet, Metabolism, and Disease
  • Liver Diseases and Immunity
  • Alcohol Consumption and Health Effects
  • Diet and metabolism studies
  • Hepatitis C virus research

Frequent publication venues for their work are:

  • Journal of Hepatology
  • Hepatology
  • Clinical Gastroenterology and Hepatology
  • The Lancet Gastroenterology & Hepatology
  • Alimentary Pharmacology & Therapeutics

Philip N. Newsome's most cited recent papers include:

  • "A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis," 2020, New England Journal of Medicine
  • "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement," 2020, Journal of Hepatology
  • "MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease," 2020, Gastroenterology
  • "A multisociety Delphi consensus statement on new fatty liver disease nomenclature," 2023, Hepatology
  • "A multisociety Delphi consensus statement on new fatty liver disease nomenclature," 2023, Journal of Hepatology

Frequent co-authors collaborating with Philip N. Newsome are:

  • Elisabetta Bugianesi
  • Vincent Wai-Sun Wong
  • Laurent Castéra
  • Jörn M. Schattenberg
  • Jérôme Boursier

Their research contributions have achieved a high volume of publications in the field of medicine, with a total of 461 works, 157 in epidemiology and 114 in hepatology specifically. This points to a sustained focus on liver-related conditions and metabolic diseases within their broader scientific investigations.

Best Publications

  • A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

    Mohammed Eslam;Philip N. Newsome;Shiv K. Sarin;Quentin M. Anstee

  • Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

    Matthew James Armstrong;Matthew James Armstrong;Piers Gaunt;Guruprasad P Aithal;Darren Barton;Darren Barton

  • A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

    Philip N. Newsome;Kristine Buchholtz;Kenneth Cusi;Martin Linder

  • Resolving the fibrotic niche of human liver cirrhosis at single cell level

    P Ramachandran;R Dobie;J R Wilson-Kanamori;E F Dora

  • Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

    Peter J. Eddowes;Magali Sasso;Michael Allison;Emmanouil Tsochatzis

  • Pathogenesis of non-alcoholic fatty liver disease

    Joanna Dowman;Jeremy Tomlinson;Philip Newsome

  • Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

    Rod S. Taylor;Rebecca J. Taylor;Sue Bayliss;Hannes Hagström

  • Addressing liver disease in the UK: A blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis

    Roger Williams;Richard Aspinall;Mark Bellis;Ginette Camps-Walsh

  • Advancing the global public health agenda for NAFLD: a consensus statement.

    Jeffrey V Lazarus;Henry E Mark;Quentin M Anstee;Juan Pablo Arab

  • FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study.

    Philip N Newsome;Philip N Newsome;Magali Sasso;Jonathan J Deeks;Jonathan J Deeks;Angelo Paredes

  • Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling

    David C. Hay;Judy Fletcher;Catherine Payne;John D. Terrace

  • Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

    Tobias Boettler;Philip N. Newsome;Philip N. Newsome;Mario U. Mondelli;Mojca Maticic

  • Guidelines on the management of abnormal liver blood tests

    Philip N. G. Newsome;Rob Cramb;Suzanne M. Davison;John F. Dillon

  • Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

    Joanna Dowman;Joanna Dowman;Jeremy Tomlinson;Philip Newsome;Philip Newsome

  • Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

    Matthew J. Armstrong;Diana Hull;Kathy Guo;Darren Barton

  • A concise review of non-alcoholic fatty liver disease

    Nwe Ni Than;Philip N. Newsome

  • Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease.

    Reenam S. Khan;Reenam S. Khan;Fernando Bril;Fernando Bril;Kenneth Cusi;Kenneth Cusi;Philip N. Newsome;Philip N. Newsome

  • Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion

    Philip N Newsome;Ingolfur Johannessen;Shelagh Boyle;Evangelos Dalakas

  • Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort.

    Matthew J. Armstrong;Diarmaid D. Houlihan;Diarmaid D. Houlihan;Louise Bentham;Jean C. Shaw

  • Liver regeneration - mechanisms and models to clinical application.

    Stuart J Forbes;Philip N Newsome

Frequent Co-Authors

Peter C. Hayes
Peter C. Hayes University of Edinburgh
Quentin M. Anstee
Quentin M. Anstee Newcastle University
Stuart J. Forbes
Stuart J. Forbes University of Edinburgh
David H. Adams
David H. Adams Mount Sinai Hospital
John P. Iredale
John P. Iredale University of Bristol
Jörn M. Schattenberg
Jörn M. Schattenberg Johannes Gutenberg University of Mainz
Guruprasad P. Aithal
Guruprasad P. Aithal University of Nottingham
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Carla C. Baan
Carla C. Baan Erasmus University Rotterdam
Vincent Wai-Sun Wong
Vincent Wai-Sun Wong Chinese University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online education can open new doors in the medical field, especially for those looking to balance studies with work or family obligations. There are a variety of pathways for individuals considering careers in healthcare, whether you’re just starting or seeking to advance your current credentials.

Many practicing nurses look for affordable advancement options, and discovering what is the cheapest rn to bsn program online can make earning a bachelor’s degree more accessible. For those without a nursing background who want a quick transition, accredited online direct entry msn programs for non-nurses offer a unique path to a master’s degree and professional licensure.

Applicants searching for less competitive programs may benefit from direct admit nursing programs, which often have simpler admission requirements. Alternatively, if you prefer a non-clinical career, training through medical billing and coding financial aid programs can prepare you for vital roles in healthcare administration.

No matter your background or goals, these flexible online pathways can help you launch or advance your healthcare career.

Best Scientists Citing Philip N. Newsome

Trending Scientists